Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

NCT04589845 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

920

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Entrectinib
DRUG: Entrectinib
DRUG: Alectinib
DRUG: Atezolizumab
DRUG: Ipatasertib
DRUG: Trastuzumab emtansine
DRUG: Inavolisib
DRUG: Belvarafenib
DRUG: Pralsetinib
DRUG: Divarasib
DRUG: Camonsertib

Sponsor

Hoffmann-La Roche